Back to search

Article

Protection against symptomatic disease with the delta and omicron BA.1/BA.2 variants of SARS-CoV-2 after infection and vaccination in adolescents: national observational test-negative case control study, August 2021 to March 2022, England

2022-08-22

Abstract excerpt

<h4>Background</h4> Little is known about the protection following prior infection with different SARS-CoV-2 variants, COVID-19 vaccination, and a combination of the two (hybrid immunity) in adolescents. <h4>Methods</h4> We used national SARS-CoV-2 testing and COVID-19 mRNA vaccination data in England to estimate protection following previous infection and vaccination against symptomatic PCR-confirmed delta and om...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
16599497-b87a-5249-91dd-72f610e66627
DOI
10.1101/2022.08.19.22278987
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Protection against symptomatic disease with the delta and omicron BA.1/BA.2 variants of SARS-CoV-2 after infection and vaccination in adolescents: national observational test-negative case control study, August 2021 to March 2022, EnglandDOI 10.1101/2022.08.19.22278987
Vaccine Effectiveness of Two-Dose BNT162b2 Over Time Against COVID-19 Symptomatic Infection and Severe Cases Among Adolescents: Test Negative Design Case Control Studies in Brazil and ScotlandSemantic proximity
Effectiveness of COVID-19 vaccines against the Omicron (B.1.1.529) variant of concernSemantic proximity
Effectiveness of Mrna Booster Vaccination Against Mild and Severe COVID-19 During Delta and Omicron Variant Circulation in Germany: An Analysis of National Surveillance DataSemantic proximity
COVID-19 Vaccine Effectiveness against the Omicron BA.2 variant in EnglandSemantic proximity
Impact of Vaccination, Prior Infection, and Therapy on Delta and Omicron VariantsSemantic proximity
Impact of SARS-CoV-2 vaccination of children ages 5-11 years on COVID-19 disease burden and resilience to new variants in the United States, November 2021-March 2022: a multi-model studySemantic proximity
Clinical Severity and mRNA Vaccine Effectiveness for Omicron, Delta, and Alpha SARS-CoV-2 Variants in the United States: A Prospective Observational StudySemantic proximity
Post COVID-19 Condition after Delta Infection and Omicron Reinfection in Children and AdolescentsSemantic proximity
Vaccination against SARS-CoV-2 in UK school-aged children and young people decreases infection rates and reduces COVID-19 symptomsSemantic proximity
Understanding SARS-CoV-2 Delta and Omicron Variant Transmission and Vaccine Impact in Schools and Child-Care Settings in AustraliaSemantic proximity
Effectiveness of Covid-19 vaccines against symptomatic and asymptomatic SARS-CoV-2 infections in an urgent care settingSemantic proximity
Comparative COVID-19 Vaccines Effectiveness in Preventing Infections, Hospitalizations, and Deaths with SARS-CoV-2 BA.5 and Ba.2 Omicron Lineages: A Case-Case and Cohort Study Using Electronic Health Records in PortugalSemantic proximity
Select a neighboring publication to make it the new centre.